Cargando…
Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma
Clear cell renal cell carcinoma (ccRCC), the most common form of Kidney cancer, is characterized by frequent mutations of the von Hippel-Lindau (VHL) tumor suppressor gene in ~85% of sporadic cases. Loss of pVHL function affects multiple cellular processes, among which the activation of hypoxia indu...
Autores principales: | Mehdi, Ali, Riazalhosseini, Yasser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578163/ https://www.ncbi.nlm.nih.gov/pubmed/28812986 http://dx.doi.org/10.3390/ijms18081774 |
Ejemplares similares
-
Emerging Targets in Clear Cell Renal Cell Carcinoma
por: Chen, Yu-Wei, et al.
Publicado: (2022) -
A Sarcomatoid Renal Cell Carcinoma with Clear Cell Papillary-Like Primary Tumor and Lymph Node Metastasis: A Diagnostic Conundrum
por: Demko, Nadine, et al.
Publicado: (2022) -
Emerging Therapies for Advanced Clear Cell Renal Cell Carcinoma
por: Toth, Alexander T., et al.
Publicado: (2020) -
Effect of Aberrant Long Noncoding RNA on the Prognosis of Clear Cell Renal Cell Carcinoma
por: Wu, Han, et al.
Publicado: (2021) -
Link between dysregulated hypoxia signaling and aberrant methylation in clear cell renal cell carcinoma?
por: Shenoy, Niraj
Publicado: (2017)